Journal ArticleAm Heart J · January 2026
BACKGROUND: Current recommendations for a prophylactic (primary prevention) implantable cardioverter defibrillator (ICD) in patients with both ischemic and nonischemic heart failure with reduced ejection fraction (HFrEF) originate from clinical trials cond ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 2025
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic ICD for the primary preve ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · April 2025
BACKGROUND: The majority of data on left bundle branch area pacing (LBBAP) are on a lumenless lead. Data on the safety and effectiveness of stylet driven leads are comparatively lacking. METHODS: We retrospectively analyzed 265 patients who underwent attem ...
Full textLink to itemCite
Journal ArticleHeart rhythm · April 2025
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic ICD for the primary preve ...
Full textCite
Journal ArticleHeart Rhythm · February 2025
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks are a common complication after left ventricular assist device (LVAD) implantation; however, data on their frequency and causes are limited. OBJECTIVE: The purpose of this study was to define ...
Full textLink to itemCite
Journal ArticleJAMA · November 26, 2024
IMPORTANCE: The emergence of novel programming guidelines that reduce premature and inappropriate therapies along with the availability of new implantable cardioverter-defibrillator (ICD) technologies lacking traditional endocardial antitachycardia pacing ...
Full textLink to itemCite
Journal ArticleKidney Int Rep · November 2024
INTRODUCTION: Individuals with end-stage kidney disease (ESKD) maintained on hemodialysis (HD) carry a high risk of cardiac arrhythmias. This risk is heightened by episodic hyperkalemia. The purpose of the study was to investigate whether patiromer adminis ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · February 2024
BACKGROUND: Data on the risk of ventricular tachycardia (VT), ventricular fibrillation (VF), and death by sex in patients with prior VT/VF are limited. OBJECTIVES: This study aimed to assess sex-related differences in implantable cardioverter-defibrillator ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · February 2024
BACKGROUND: Cerebral microembolization and atrophy complicate atrial fibrillation (AF). OBJECTIVES: We aimed to compare changes in neuroimaging findings between AF patients treated with catheter ablation and those treated with medical therapy. METHODS: In ...
Full textLink to itemCite
Journal ArticleAm J Cardiovasc Drugs · November 2023
BACKGROUND: There is evidence to suggest that colchicine reduces the risk of recurrent atrial fibrillation (AF) after catheter ablation; however, the tolerability and safety of colchicine in routine practice is unknown. METHODS: Patients undergoing cathete ...
Full textLink to itemCite
Journal ArticleEuropean Heart Journal · November 1, 2023
Introduction: Patients (pts) implanted with an ICD for a primary prevention (PP) typically receive concomitant medications (meds) to treat LV dysfunction. However, It is not well established whether compliance with guideline-directed medical therapy (GDMT) ...
Full textCite
Journal ArticleExpert Rev Med Devices · 2023
INTRODUCTION: Atrial fibrillation (AF) ablation is being performed more frequently and more widely at more centers. This stems from several factors including 1) demographic forces leading to an increased prevalence of the arrhythmia; 2) greater availabilit ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · November 1, 2022
The Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy showed a significant reduction in the risk of inappropriate therapy in patients with a programmed high-rate cutoff ≥200 beats per minute or delayed therapy for events ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · October 2022
BACKGROUND: Inherited primary arrhythmia syndromes and arrhythmogenic cardiomyopathies can lead to sudden cardiac arrest in otherwise healthy individuals. The burden and expression of these diseases in a real-world, well-phenotyped cardiovascular populatio ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · July 2022
BACKGROUND: Atrial pacing and right ventricular (RV) pacing are both associated with adverse outcomes among patients with first-degree atrioventricular block (1°AVB). His-bundle pacing (HBP) provides physiological activation of the ventricle and may be abl ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · June 2022
BACKGROUND: The RAID (Ranolazine Implantable Cardioverter-Defibrillator) randomized placebo-controlled trial showed that ranolazine treatment was associated with reduction in recurrent ventricular tachycardia (VT) requiring appropriate implantable cardiove ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · March 2022
BACKGROUND: Cardiac implanted electronic device (CIED) pocket and systemic infection remain common complications with traditional CIEDs and are associated with high morbidity and mortality. Leadless pacemakers may be an attractive pacing alternative for ma ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · January 2022
OBJECTIVES: This study sought to determine the association of cardiomyopathy etiology with the likelihood of ventricular arrhythmias, appropriate implantable cardioverter-defibrillator (ICD) therapy, and mortality. BACKGROUND: There are conflicting data on ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · October 2021
BACKGROUND: Atrioventricular (AV)-synchronous single-chamber leadless pacing using a mechanical atrial sensing algorithm produced high AV synchrony in clinical trials, but clinical practice experience with these devices has not yet been described. OBJECTIV ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · August 2021
BACKGROUND: Ventricular arrhythmias (VAs) and electrical storm (ES) are recognized complications following left ventricular assist device (LVAD) implantation; however, their association with long term-outcomes remains poorly understood. OBJECTIVE: The purp ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · August 2021
BACKGROUND: The value of antitachycardia pacing (ATP) in the overall cohort of primary prevention patients who receive implantable cardioverter-defibrillators (ICDs) remains uncertain. ATP success reported in prior trials potentially included a large numbe ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 25, 2021
BACKGROUND: There are conflicting data on the impact of implantable cardioverter-defibrillator (ICD) shocks on subsequent mortality. OBJECTIVES: The aim of this study was to determine whether the arrhythmic substrate leading to ICD therapy or the therapy i ...
Full textLink to itemCite
Journal ArticleEur Heart J · May 1, 2021
AIMS: The benefit of prophylactic implantable cardioverter-defibrillator (ICD) is not uniform due to differences in the risk of life-threatening ventricular tachycardia (VT)/ventricular fibrillation (VF) and non-arrhythmic mortality. We aimed to develop an ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · March 2021
BACKGROUND: In Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy (MADIT-RIT), high-rate cutoff (arm B) and delayed therapy (arm C) reduced the risk of inappropriate implantable cardioverter-defibrillator (ICD) interventi ...
Full textLink to itemCite
Chapter · January 1, 2021
Cardiac implantable electrical devices (CIEDs) refer to implanted devices that deliver therapeutic electrical stimuli and include permanent pacemakers and implantable cardioverter-defibrillators (ICDs). Electrical therapy for cardiac arrhythmias includes l ...
Full textCite
Journal ArticleHeart Rhythm · September 2020
BACKGROUND: There are limited data on the performance of the subcutaneous implantable cardioverter-defibrillator (S-ICD) in patients with a left ventricular assist device (LVAD). OBJECTIVE: The purpose of this study was to describe the clinical course and ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · September 2020
BACKGROUND: Cardiac amyloidosis is a progressive infiltrative disease involving deposition of amyloid fibrils in the myocardium and cardiac conduction system that frequently manifests with heart failure (HF) and arrhythmias, most frequently atrial fibrilla ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · September 2020
OBJECTIVES: This study sought to determine the indications, characteristics, and outcomes of cardiovascular implantable electronic device (CIED) surgery in patients with LVAD. BACKGROUND: Many patients with a left ventricular assist device (LVAD) will requ ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · August 18, 2020
BACKGROUND: Monogenic diseases are individually rare but collectively common, and are likely underdiagnosed. OBJECTIVES: The purpose of this study was to estimate the prevalence of monogenic cardiovascular diseases (MCVDs) and potentially missed diagnoses ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · August 2020
BACKGROUND: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. OBJECTIVE: The purpose of this study was to compa ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Clin Electrophysiol · June 2020
OBJECTIVES: The goal of this study was to assess the utility of transvenous lead extraction for cardiovascular implantable electronic device (CIED) infection in patients with a left ventricular assist device (LVAD). BACKGROUND: The use of transvenous lead ...
Full textLink to itemCite
Journal ArticleJ Arrhythm · April 2020
BACKGROUND: Focal impulse and rotor modulation (FIRM) can cause slowing, organization, and occasionally termination of atrial fibrillation (AF), although results have been mixed. To further characterize changes in AF during rotor ablation, we quantified mo ...
Full textLink to itemCite
Journal ArticleAm Heart J · February 2020
BACKGROUND: Pulmonary wall isolation (PWI) is increasingly used as an adjunctive lesion set to compliment pulmonary vein isolation (PVI), especially in patients with persistent atrial fibrillation (AF). The objective was to compare outcomes of catheter abl ...
Full textLink to itemCite
Journal ArticleJ Arrhythm · February 2020
BACKGROUND: Catheter ablation is an important rhythm control therapy in patients with atrial fibrillation (AF) with concomitant heart failure (HF). The objective of this study was to assess the comparative efficacy of AF ablation patients with ischemic vs ...
Full textOpen AccessLink to itemCite
Journal ArticleEuropace · December 1, 2019
AIMS: There are limited data regarding factors that identify implantable cardioverter-defibrillator (ICD) patients who will experience either ventricular tachyarrhythmic (VTA) or non-arrhythmic (NA) mortality, and the commonly used clinical classification ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · November 2019
Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders. This des ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · November 2019
BACKGROUND: Compared with medical therapy, catheter ablation of atrial fibrillation (AF) in patients with heart failure (HF) improves cardiovascular outcomes. Risk scores (CAAP-AF and APPLE) have been developed to predict the likelihood of AF recurrence af ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · November 2019
Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders. This des ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2019
BACKGROUND: Hispanics/Latinos represent the largest ethnic minority group in the United States. Atrial fibrillation (AF) is the most common cardiac arrhythmia in the United States. OBJECTIVE: The purpose of this study was to provide data on the prevalence ...
Full textLink to itemCite
Chapter · April 5, 2019
Three-dimensional electroanatomical mapping (EAM) systems realistically made it feasible to map focal or reentrant arrhythmias from one of the cardiac chambers. The importance of optimized detailed and accurate mapping within the regions previously conside ...
Full textCite
Chapter · April 5, 2019
Mapping and elimination (ablation) of an abnormal cardiac rhythm requires an understanding of normal and abnormal anatomy and physiology, and monitoring of the interventional catheters and ablation energy’s effects. Cardiac electrophysiology has evolved en ...
Full textCite
Chapter · April 5, 2019
Accessory pathways (APs) are one of the longest standing targets for mapping and ablation, previously surgical but now almost exclusively catheter based. This chapter reviews the electrocardiographic and catheter-based principles of mapping related to APs. ...
Full textCite
Journal ArticleJ Am Coll Cardiol · January 8, 2019
Sudden cardiac arrest (SCA) is one of the largest causes of mortality globally, with an out-of-hospital survival below 10% despite intense research. This document outlines challenges in addressing the epidemic of SCA, along the framework of respond, unders ...
Full textLink to itemCite
Chapter · January 1, 2019
Posteroseptal accessory pathways (APs) are actually not septal but reside in a complex region bordering the right atrium, right ventricle, left ventricle, left atrium and coronary sinus and its branches. Posteroseptal APs are among the most challenging to ...
Full textCite
Journal ArticleEuropace · November 1, 2018
AIMS: To assess whether obstructive sleep apnea (OSA) was associated with increased rotor burden among atrial fibrillation (AF) patients. METHODS AND RESULTS: We studied 33 consecutive patients who were scheduled for focal impulse and rotor modulation (FIR ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · October 2018
INTRODUCTION: Data on inappropriate and appropriate ICD therapy, and efficacy of ICD programing strategies by race are limited. METHODS: In MADIT-RIT, we evaluated the risk of ICD therapy by race, and the efficacy of high rate cut-off ventricular tachycard ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · August 7, 2018
BACKGROUND: Ventricular tachycardia (VT) and ventricular fibrillation (VF) remain a challenging problem in patients with implantable cardioverter-defibrillators (ICDs). OBJECTIVES: This study aimed to determine whether ranolazine administration decreases t ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · August 2018
With the emergence of cardiac resynchronization therapy (CRT) as a powerful tool to reverse left ventricular dysfunction in patients with left bundle branch block (LBBB), there is increasing awareness that LBBB-induced dyssynchrony may be a primary cause o ...
Full textLink to itemCite
Journal ArticleHealth Sci Rep · June 2018
BACKGROUND: The optimal way of pacing in patients with an indication for pacing and concomitant first-degree atrioventricular (AV)-block is not known, and consequently, firm guidelines on this topic are lacking. This study explored the current pacemaker pr ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2018
BACKGROUND: Few studies have examined outcomes of catheter ablation for atrial fibrillation (AF) in patients with heart failure (HF) with preserved ejection fraction (HFpEF). OBJECTIVE: The purpose of this study was to compare outcomes of AF ablation in pa ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · April 2018
BACKGROUND: Compared with men, women have longer corrected QT (QTc) intervals, lower clearance of dofetilide, and higher rates of drug-induced torsades de pointes, but the dofetilide dosing algorithm is the same for men and women. OBJECTIVE: The purpose of ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · March 2018
BACKGROUND: Frequent ventricular ectopy on preimplantation Holter has been associated with attenuated benefit from cardiac resynchronization therapy (CRT). However, it is unclear whether ectopic burden measured post-CRT implantation can be utilized to eval ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · January 23, 2018
BACKGROUND: Patients with left bundle branch block (LBBB) often respond to cardiac resynchronization therapy (CRT) with left ventricular ejection fraction (LVEF) improvement. Guideline-directed medical therapy (GDMT), not CRT, is first-line therapy for pat ...
Full textLink to itemCite
Chapter · January 1, 2018
Congestive heart failure (CHF) is a resource-intensive and costly chronic disease. Current indications for implantation of cardiac resynchronization therapy (CRT) include the presence of severe cardiomyopathy and evidence of ventricular conduction delay on ...
Full textCite
Book · January 1, 2018
A complete, how-to-do-it guide to planning, programming, implementing, and trouble-shooting today's pacemakers and other implantable cardiac devices Edited by a team of leading clinician-educators this is a practical, go-to reference for trainees and clini ...
Full textCite
Journal ArticleAm J Cardiol · December 1, 2017
We compared the incidence of left ventricular systolic dysfunction (LVSD) among patients with left bundle branch block (LBBB) to a matched cohort of patients with a narrow QRS duration <120 ms (NQRS). We hypothesized patients with preserved ejection fracti ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · December 2017
BACKGROUND: The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter-defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · September 2017
BACKGROUND: Atrioesophageal fistula formation is a rare but life-threatening complication of atrial fibrillation ablation. Contact force (CF)-sensing catheters improve procedural effectiveness. However, the impact of the implementation of CF-sensing techno ...
Full textLink to itemCite
Journal ArticleEuropace · July 1, 2017
AIMS: Antiarrhythmic medications for the treatment of atrial fibrillation (AF) have limited efficacy and rare but potentially life-threatening side effects. Ranolazine is an antianginal agent that may have antiarrhythmic activity in AF. METHODS AND RESULTS ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2017
Patients with diabetes mellitus, prior myocardial infarction, older age, and a relatively preserved left ventricular ejection fraction remain at risk for sudden cardiac death that is potentially amenable by the subcutaneous implantable cardioverter defibri ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2017
UNLABELLED: Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. METHODS: We evaluated changes in QoL from baseline to 9-month follow-up ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · June 2017
OBJECTIVES: This analysis evaluated temporal trends and factors associated with the use of dual-coil implantable cardioverter-defibrillator (ICD) leads. BACKGROUND: Data suggest that dual-coil ICD leads are not associated with lower mortality and can be mo ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 16, 2017
BACKGROUND: Data regarding cardiac resynchronization therapy (CRT) in patients with multiple comorbidities are limited. OBJECTIVES: This study evaluated the association of multiple comorbidities with the benefits of CRT over implantable cardioverter-defibr ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · April 2017
BACKGROUND: Symptomatic sinus node dysfunction (SND) consists of a variety of manifestations, including tachycardia-bradycardia syndrome. Atrial fibrillation (AF) is commonly associated with SND, which complicates the management of both conditions. This pa ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · April 1, 2017
The utility of routine transesophageal echocardiography (TEE) to exclude left atrial appendage (LAA) thrombus before atrial fibrillation (AF) ablation in patients treated with nonvitamin K oral anticoagulant (NOAC) therapy is unclear. This single-center re ...
Full textLink to itemCite
Journal ArticleClin Transplant · April 2017
BACKGROUND: Postoperative atrial arrhythmias (AAs) are common after lung transplantation, but studies are mixed regarding their impact on outcomes. We therefore performed this systematic review and meta-analysis to determine whether AAs after lung transpla ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · April 2017
INTRODUCTION: The role of atrial fibrillation (AF) substrates is unclear in patients with paroxysmal AF (PAF) that recurs after pulmonary vein isolation (PVI). We hypothesized that patients with recurrent post-ablation (redo) PAF despite PVI have electrica ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · January 2017
INTRODUCTION: Approximately 10-20% of ICD recipients receive inappropriate device therapies. The purpose of this study was to compare the frequency of inappropriate therapies (IT) between men and women enrolled in MADIT II and MADIT-CRT, and assess for pot ...
Full textLink to itemCite
Journal ArticleHeart Fail Clin · January 2017
Cardiac resynchronization therapy (CRT) improves left ventricular function, especially in patients with left bundle branch block or those receiving chronic right ventricular pacing. CRT is typically accomplished by placing a right ventricular endocardial p ...
Full textLink to itemCite
Journal ArticleCirculation · November 22, 2016
BACKGROUND: A prolonged PR interval is common among cardiac resynchronization therapy (CRT) candidates; however, the association between PR interval and outcomes is unclear, and the data are conflicting. METHODS: We conducted inverse probability weighted a ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · July 2016
BACKGROUND: Patients with an unused or malfunctioning implantable cardioverter-defibrillator (ICD) lead may have the lead either abandoned or explanted; yet there are limited data on the comparative acute and longer-term safety of these 2 approaches. METHO ...
Full textLink to itemCite
Journal ArticleCan J Anaesth · April 2016
BACKGROUND: We characterized cardiac surgery-induced dynamic changes of the corrected QT (QTc) interval and tested the hypothesis that genetic factors are associated with perioperative QTc prolongation independent of clinical and procedural factors. METHOD ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · March 2016
BACKGROUND: Patients with ischemic heart disease may have implantable cardioverter defibrillators (ICDs) implanted for primary or secondary prevention of sudden cardiac death. Although ICD shocks can be life saving, in some patients, they have been associa ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · January 2016
BACKGROUND: The Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate therapy (MADIT-RIT) trial showed a significant reduction in inappropriate implantable cardioverter defibrillator (ICD) therapy in patients programmed to high-rate c ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2016
BACKGROUND: There is a need for improved selection criteria for Cardiac Resynchronization Therapy (CRT). High myocardial scar burden has been associated with worse outcome in CRT patients. It is, however, unclear whether high scar burden ameliorates CRT cl ...
Full textLink to itemCite
Journal ArticleIndian Pacing Electrophysiol J · 2016
BACKGROUND: The goal of this study is to assess the effect of cardiac resynchronization therapy (CRT) over time on renal function and its impact on mortality. The effect of CRT on renal function in patients with heart failure is not well understood. METHOD ...
Full textLink to itemCite
Journal ArticleCard Electrophysiol Clin · December 2015
Cardiac resynchronization therapy (CRT) improves left ventricular function, especially in patients with left bundle branch block or those receiving chronic right ventricular pacing. CRT is typically accomplished by placing a right ventricular endocardial p ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · September 2015
BACKGROUND: Data on inappropriate implantable cardioverter-defibrillator (ICD) therapy and effects of programming by heart rate are lacking. OBJECTIVE: We aimed to characterize inappropriate ICD therapy and assess the effects of novel programming by heart ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · August 2015
BACKGROUND: There are limited data whether history of atrial tachyarrhythmia (AT) modifies the risk of inappropriate ICD therapy, or the efficacy of novel ICD programming to reduce inappropriate ICD therapy events. METHODS: In MADIT-RIT, we investigated th ...
Full textLink to itemCite
Journal ArticleEuropace · July 2015
AIMS: Data on the time-dependent benefit of cardiac resynchronization therapy with defibrillator (CRT-D) compared with a dual-chamber implantable cardioverter-defibrillator (ICD) to reduce death or ventricular tachycardia (VT) or ventricular fibrillation ( ...
Full textLink to itemCite
Journal ArticleEuropace · June 2015
AIMS: Recently, a U-shaped association between PR-interval and the risk of developing atrial fibrillation was described, with higher risk in patients with long and short PR-intervals. Little is known regarding the association of PR-interval duration and mo ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · June 2015
PURPOSE: While the accuracy of roentography for evaluation of lead tip position compared with three-dimensional imaging techniques has been well described, there remains considerable variability in the interpretation of the reproducibility of standard x-ra ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2015
BACKGROUND: The Riata class of defibrillator leads were placed under US Food and Drug Association (FDA) advisory as of November 2011 because of high rates of cable externalization (CE) and electrical failure (EF). The overall rates of these complications r ...
Full textOpen AccessLink to itemCite
Journal ArticleEur Heart J · February 14, 2015
AIMS: Previous studies on biventricular (BIV) pacing and cardiac resynchronization therapy-defibrillator (CRT-D) efficacy have used arbitrarily chosen BIV pacing percentages, and no study has employed implantable cardioverter defibrillator (ICD) patients a ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · February 2015
INTRODUCTION: We conducted this pilot randomized clinical trial to determine the feasibility of a large clinical trial aimed at testing whether early use of catheter ablation of ventricular tachycardia (VT) is superior to antiarrhythmic medications at redu ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2015
INTRODUCTION: Electrocardiographic (ECG) LV scar quantification may improve prediction of CRT response. METHODS AND RESULTS: Data were abstracted in 76 patients who underwent a first CRT implantation at 2 US centers. Selvester QRS scar quantification was p ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · December 2014
BACKGROUND: Battery failure is an uncommon complication of implantable cardioverter-defibrillators (ICDs), but unanticipated battery depletion can have life-threatening consequences. OBJECTIVE: The purpose of this study was to describe the prevalence of a ...
Full textLink to itemCite
Journal ArticleHeart · December 2014
OBJECTIVE: Catheter ablation of atrial fibrillation (AF) has become an increasingly safe and effective therapy. This has been partly attributed to the use of adjunctive imaging modalities. We aimed to describe the use and associated outcomes of periprocedu ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · December 2014
INTRODUCTION: Several groups report electrical rotors or focal sources that sustain atrial fibrillation (AF) after it has been triggered. However, it is difficult to separate stable from unstable activity in prior studies that examined only seconds of AF. ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · November 2014
INTRODUCTION: Heart failure patients with left ventricular assist devices (LVADs) are at risk for infection. Cardiac implantable electronic devices (CIEDs) are commonly present in these patients. The course of infections in patients with an LVAD and a CIED ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · October 2014
BACKGROUND: The benefit of novel implantable cardioverter defibrillator (ICD) programming in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · October 2014
BACKGROUND: Preprocedural multidetector computed tomography (MDCT) may identify patients at risk for mechanical complications during lead extraction. METHODS: To describe the use and feasibility of computed tomography scanning for preprocedural planning of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · September 9, 2014
BACKGROUND: A high percentage of biventricular pacing is required for optimal outcome in patients treated with cardiac resynchronization therapy (CRT), but the influence of ectopic beats on the success of biventricular pacing has not been well established. ...
Full textLink to itemCite
Journal ArticleEuropace · September 2014
AIMS: Atrial fibrillation (AF) and coronary artery disease (CAD) are common in older patients. We aimed to describe the use of antiarrhythmic drug (AAD) therapy and clinical outcomes in these patients. METHODS AND RESULTS: We analysed AAD therapy and outco ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · September 2014
BACKGROUND: Patients with a pacing indication and first-degree atrioventricular (AV)-block pose a clinical challenge. The prognostic impact of first-degree AV-block in patients with sinus node dysfunction and the impact of pacing in this setting are not kn ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · September 2014
INTRODUCTION: The success of pulmonary vein isolation (PVI) for atrial fibrillation (AF) may be improved if stable AF sources identified by Focal Impulse and Rotor Mapping (FIRM) are also eliminated. The long-term results of this approach are unclear outsi ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 1, 2014
Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF). Although randomized studies have found that sotalol can significantly delay time to AF recurrence, its association with ...
Full textLink to itemCite
ConferenceCirc Arrhythm Electrophysiol · August 2014
BACKGROUND: In Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT), patients with non-left bundle branch block (LBBB; including right bundle branch block, intraventricular conduction delay) did not have clin ...
Full textLink to itemCite
Journal ArticleN Engl J Med · May 1, 2014
BACKGROUND: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) showed that early intervention with cardiac-resynchronization therapy with a defibrillator (CRT-D) in patients with an electrocardiogr ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 1, 2014
OBJECTIVES: This study aimed to investigate the effect of both history of intermittent atrial tachyarrhythmias (IAT) and in-trial IAT on the risk of heart failure (HF) or death comparing cardiac resynchronization therapy with defibrillator (CRT-D) to impla ...
Full textLink to itemCite
Journal ArticleEur Heart J · January 2014
OBJECTIVE: The aim of the present study was to assess a possible association between myocardial substrate, implantable cardioverter defibrillator (ICD) shocks, and subsequent mortality. METHODS: Within the multicentre automatic defibrillator implantation t ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · October 2013
BACKGROUND: Implantable cardioverter defibrillator (ICD)-delivered shocks can cause substantial distress, warranting consideration of ICD deactivation at end of life. This study was designed to describe the patterns of end-of-life management in patients wi ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · September 2013
BACKGROUND: Low left ventricular ejection fraction (LVEF) increases risk for both sudden cardiac death (SCD) and for heart failure (HF) death; however, implantable cardioverter-defibrillators (ICDs) reduce the incidence of SCD, not HF death. Distinguishing ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · September 2013
PURPOSE: Dabigatran is approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). The safety and effectiveness of periprocedural dabigatran in ablation for AF are unknown. METHODS: We performed a meta-anal ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · May 2013
BACKGROUND: Proper positioning of the left ventricular (LV) lead improves clinical outcomes and survival in patients receiving cardiac resynchronization therapy (CRT). Techniques of LV lead insertion using contrast injection and a telescoping system of del ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · May 2013
First-degree atrioventricular (AV) block is a delay within the AV conduction system and is defined as a prolongation of the PR interval beyond the upper limit of what is considered normal (generally 0.20 s). Up until recently, first-degree AV block was con ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · April 2013
OBJECTIVES: The purpose of this study was to determine whether exercise training is associated with an increased risk of implantable cardioverter-defibrillator (ICD) therapy in patients with heart failure (HF). BACKGROUND: Few data are available regarding ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · February 2013
BACKGROUND: Defibrillation threshold (DFT) testing is commonly practiced at the time of implantable cardioverter-defibrillator (ICD) implant. The clinical consequence of ICD shocks delivered during DFT testing is unknown. OBJECTIVE: The purpose of this stu ...
Full textLink to itemCite
Journal ArticleN Engl J Med · December 13, 2012
BACKGROUND: The implantable cardioverter-defibrillator (ICD) is highly effective in reducing mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are frequent, with potential adverse effects. METHODS: We randomly assign ...
Full textLink to itemCite
Journal ArticleCirculation · October 30, 2012
BACKGROUND: Atrial fibrillation is common among older persons. Catheter ablation is increasingly used in patients for whom medical therapy has failed. METHODS AND RESULTS: We conducted a retrospective cohort study of all fee-for-service Medicare beneficiar ...
Full textLink to itemCite
Journal ArticleAm Heart J · September 2012
BACKGROUND: In several studies, prolongation of the corrected QT (QTc) interval has been associated with an increased risk of cardiac events. However, data on race and gender variation in the QTc and its associated risk of death are lacking. METHODS: We pr ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · July 2012
The implantable cardioverter defibrillator (ICD) is highly effective in reducing mortality due to cardiac arrhythmias in high-risk cardiac patients. However, inappropriate therapies caused predominantly by supraventricular tachyarrhythmias (SVTs) remain a ...
Full textLink to itemCite
Journal ArticleHeart · May 2012
Sudden cardiac arrest is the one of the most common causes of death in developed countries and accounts for between 180,000 and over 450,000 per year in the USA. Antiarrhythmic drug approaches to prevention of sudden cardiac death have been resoundingly in ...
Full textLink to itemCite
Journal ArticleProg Cardiovasc Dis · 2012
Implantable cardioverter-defibrillator (ICD) therapy improves survival in patients with significant left ventricular systolic dysfunction. Although this lifesaving therapy has many benefits, inappropriate ICD shocks may increase morbidity and mortality. Wi ...
Full textLink to itemCite
Journal Article · December 1, 2011
A 51-year-old man on chronic methadone therapy for a history of heroin abuse presented to the emergency room with cough and dyspnea. On exam he was found to be tachypneic and pulse oximetry showed a saturation of 88% on room air and a portable chest X-ray ...
Full textCite
Journal Article · December 1, 2011
A 13-year-old boy is being evaluated for syncope. At the time of the syncopal event, he was a national, junior tennis champion, but had recently complained of increased fatigue and shortness of breath while playing tennis. One month previously, his brother ...
Full textCite
Journal Article · December 1, 2011
A 19-year-old college swimmer suffered syncope during an intercollegiate race. She described losing consciousness for two seconds, and coming to the surface gasping for air and choking. Over the prior month she had also had 2-3 episodes of palpitations, on ...
Full textCite
Journal Article · December 1, 2011
A 6-ft 3-in., 16-year-old male who was a high-school varsity soccer and basketball player was referred to pediatric cardiology to rule out Marfan's syndrome based on his tall slim body habitus and occasional joint aches. The patient denied any history of p ...
Full textCite
Journal ArticleJ Interv Card Electrophysiol · December 2011
Atrial fibrillation (AF) is a significant burden to the public health. AF is associated with increased morbidity and mortality, including an increased risk of heart failure, stroke, cognitive impairment, and diminished quality of life. Catheter ablation is ...
Full textLink to itemCite
Journal ArticleEur Heart J · July 2011
Featured Publication
AIMS: There are no data regarding the differential response to cardiac resynchronization therapy with defibrillator (CRT-D) by the aetiology of cardiomyopathy in mildly symptomatic patients. We evaluated the outcome of patients enrolled in MADIT-CRT by isc ...
Full textLink to itemCite
Journal ArticleCirculation · March 22, 2011
Featured Publication
BACKGROUND: An important determinant of successful cardiac resynchronization therapy for heart failure is the position of the left ventricular (LV) pacing lead. The aim of this study was to analyze the impact of the LV lead position on outcome in patients ...
Full textLink to itemCite
Journal ArticleCirculation · March 15, 2011
Featured Publication
BACKGROUND: This study aimed to determine whether QRS morphology identifies patients who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether it influences the risk of primary and secondary end points in patients enrolled ...
Full textLink to itemCite
Journal ArticleCardiol Res · February 2011
BACKGROUND: The aim of this study was to evaluate the overall use of implantable cardioverter defibrillators (ICD) for primary prevention of sudden cardiac arrest (SCA), among eligible patients from an outpatient cardiology clinic and to determine what fac ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · February 2011
Featured Publication
UNLABELLED: INTRODUCTION: Cardiovascular magnetic resonance imaging (cMRI) may provide a noninvasive method to test for pulmonary vein (PV) isolation after ablation for atrial fibrillation (AF) by detecting changes in PV contraction. METHODS: PV contract ...
Full textLink to itemCite
Journal ArticleCurr Opin Cardiol · January 2011
Featured Publication
PURPOSE OF REVIEW: Atrial fibrillation is increasingly prevalent among older adults and is a major contributor to morbidity in this population due to associated strokes, heart failure, and quality of life impairment. Catheter ablation for atrial fibrillati ...
Full textLink to itemCite
Journal ArticleResuscitation · December 2010
Featured Publication
INTRODUCTION: Therapeutic hypothermia has been shown to provide neuroprotection and improved survival in patients suffering a cardiac arrest. We report outcomes of consecutive patients receiving therapeutic hypothermia for cardiac arrest and describe predi ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · August 1, 2010
Featured Publication
INTRODUCTION: Catheter-directed atrial fibrillation (AF) ablation is contraindicated among patients with left atrial appendage (LAA) thrombus. The prevalence of LAA thrombus among fully anticoagulated patients undergoing AF ablation is unknown. METHODS AND ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · May 1, 2010
The effects of radiofrequency catheter ablation (RFCA) on left atrial (LA) size, volumes, and function in patients with atrial fibrillation (AF) are not well understood. The aim of this study was to systematically review the effects of RFCA on LA size, vol ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · May 2010
Featured Publication
BACKGROUND: Recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA) has been well established and is in part related to left atrial (LA) size. The purpose of this study was to assess the predictive capability of LA diameter (LA ...
Full textLink to itemCite
Journal ArticleCirculation · April 6, 2010
BACKGROUND: In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical featu ...
Full textLink to itemCite
Journal ArticleEur Heart J · April 2010
Featured Publication
BACKGROUND: In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical featu ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · January 1, 2010
The Medtronic Sprint Fidelis leads (models 6930, 6931, 6948, 6949) are 6.6-F bipolar high-voltage implantable cardioverter-defibrillator electrodes that were first introduced in September 2004. In October 2007, Fidelis leads were removed from the market. W ...
Full textLink to itemCite
Journal ArticleCardiol J · 2010
BACKGROUND: Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation. METHODS: We conducted a survey of primary care physicians a ...
Link to itemCite
Journal ArticleAm J Cardiol · December 15, 2009
Electrocardiographic (ECG) abnormalities are common in hypertrophic cardiomyopathy (HC) and have been associated with the distribution of left ventricular hypertrophy and myocardial fibrosis. Such abnormalities may predispose patients to electrophysiologic ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · December 2009
INTRODUCTION: Implantable cardioverter-defibrillator (ICD) therapy is well established in preventing sudden cardiac death in patients with left ventricular dysfunction. The influence of right ventricular (RV) function on ICD therapy for sudden cardiac deat ...
Full textLink to itemCite
Journal ArticleN Engl J Med · October 1, 2009
Featured Publication
BACKGROUND: This trial was designed to determine whether cardiac-resynchronization therapy (CRT) with biventricular pacing would reduce the risk of death or heart-failure events in patients with mild cardiac symptoms, a reduced ejection fraction, and a wid ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · September 2009
Featured Publication
BACKGROUND: Cardiac magnetic resonance imaging (CMR) can accurately determine infarct size. Prior studies using indirect methods and CMR to assess infarct size have shown that patients with larger myocardial infarctions have worse prognoses. Implantable ca ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · August 2009
Atrioventricular nodal (AVN) ablation with concomitant pacemaker implantation is one of the strategies that reduce symptoms in patients with atrial fibrillation (AF). However, the long-term adverse effects of right ventricular (RV) apical pacing have led t ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · July 2009
Featured Publication
BACKGROUND: Prior reports on patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) focused on individuals with advanced forms of the disease. Data on the diagnostic performance of various testing modalities in newly identified in ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · June 15, 2009
Loss of biventricular (BiV) pacing occurs during ventricular sensed events such as frequent ventricular ectopy, nonsustained ventricular tachycardia, and intrinsic atrioventricular nodal conduction, such as in atrial fibrillation. Ventricular sense respons ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · June 2009
Featured Publication
OBJECTIVES: We evaluated whether electrophysiologic (EP) inducibility predicts the subsequent occurrence of spontaneous ventricular tachycardia (VT) or ventricular fibrillation (VF) in the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation ( ...
Full textLink to itemCite
Journal ArticleEchocardiography · April 2009
A 78-year-old man with an implantable cardioverter-defibrillator (ICD) for ischemic cardiomyopathy and prior ventricular tachycardia (VT) ablation presented with abdominal pain and was found to have a small bowel obstruction requiring immediate surgery. Hi ...
Full textLink to itemCite
Journal ArticleCardiol J · 2009
Heart failure continues to be a major public health problem with high morbidity and mortality rates, despite the advances in medical treatment. Advanced heart failure patients have severe persistent symptoms and a poor quality of life. Cardiac resynchroniz ...
Link to itemCite
Journal ArticleCardiol J · 2009
Catheter ablation has emerged as an important therapy for the management of drug refractory symptomatic paroxysmal and persistent atrial fibrillation (AF). Although the elderly account for the majority of patients with AF, limited data exists regarding the ...
Link to itemCite
Journal ArticleMayo Clin Proc · October 2008
Clinical guidance is deficient regarding deactivation of implantable cardioverter-defibrillators (ICDs) in patients with terminal illnesses. We hypothesized that many physicians are apprehensive about discussing ICD deactivation with their dying patients. ...
Full textLink to itemCite
Journal ArticleCleve Clin J Med · August 2008
Featured Publication
Congenital long QT syndrome is an inherited disorder of cardiac repolarization that predisposes to syncope and to sudden death from polymorphic ventricular tachycardia. The disorder should be suspected when the electrocardiogram shows characteristic QT abn ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · July 2008
Featured Publication
BACKGROUND: Atrial flutter (AFL) is commonly treated by radiofrequency catheter ablation. Catheter-based cryoablation may be an effective alternative with potential advantages. OBJECTIVE: The purpose of this study was to study the acute and long-term safet ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2008
BACKGROUND: There is conflicting literature on the relationship between prolonged QRS duration (QRSd) and arrhythmic events, including sudden cardiac death (SCD), in heart failure patients with or without implantable cardioverter-defibrillators (ICDs). OBJ ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 8, 2008
Featured Publication
OBJECTIVES: This study sought to identify the incidence and outcome related to inappropriate implantable cardioverter-defibrillator (ICD) shocks, that is, those for nonventricular arrhythmias. BACKGROUND: The MADIT (Multicenter Automatic Defibrillator Impl ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · March 2008
We report a rare case of inadvertent reversal of the defibrillator shock coils during generator change which then resulted in both intermittent, recurrent "noise" on both the rate sensing and the shock electrogram leads and multiple inappropriate shocks. ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · February 2008
Featured Publication
BACKGROUND: The availability of stored intracardiac electrograms from implantable defibrillators (ICDs) has facilitated the study of the mechanisms of ventricular tachyarrhythmia onset. This study aimed to determine the patterns of initiation of ventricula ...
Full textLink to itemCite
Journal ArticleAm Heart J · January 2008
Featured Publication
BACKGROUND: Prior reports describing magnetic resonance (MR) imaging abnormalities in arrhythmogenic right ventricular dysplasia (ARVD/C) were limited by nonuniform inclusion criteria. The aim of our study was to define the prevalence, sensitivity, and spe ...
Full textLink to itemCite
Journal ArticleCardiol J · 2008
BACKGROUND: To systematically review the benefits of cardiac resynchronization therapy (CRT) in heart failure patients with narrow QRS (< 120 ms) who have baseline mechanical asynchrony. METHODS: We searched the MEDLINE, Cochrane Central Register of Contro ...
Link to itemCite
Journal ArticleProg Cardiovasc Dis · 2008
Featured Publication
The clinical use of the implantable cardioverter-defibrillator (ICD) is well established to prevent sudden death in patients with left ventricular dysfunction due to coronary artery disease and dilated cardiomyopathy, and its use has saved thousands of liv ...
Full textLink to itemCite
Journal ArticleCardiol J · 2008
Torsade de pointes (TdP) is increasingly recognized as a complication of drug therapy. The most common cause of drug-induced QT prolongation is inhibition of the rapidly activating component of the delayed potassium current (I(Kr)). Moxifloxacin, a widely ...
Link to itemCite
Journal ArticleAnnu Int Conf IEEE Eng Med Biol Soc · 2008
Inappropriate shocks due to misclassification of supraventricular and ventricular arrhythmias remain a major problem in the care of patients with Implantable Cardioverter defibrillators (ICDs). In this study we have investigated the ability of a new covari ...
Full textLink to itemCite
Journal Article · December 1, 2007
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease characterized by specific right ventricular (RV) involvement and risk of arrhythmic sudden death [1-3]. Distinctive pathologic feature is RV myocardial ...
Full textCite
Journal ArticleHeart Rhythm · November 2007
Featured Publication
BACKGROUND: Much of prognostic implications of ventricular arrhythmia storms remain unclear. OBJECTIVE: We evaluated the risk associated with electrical storm in patients with defibrillators in the Multicenter Automatic Defibrillator Implantation Trial II ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · August 2007
Featured Publication
INTRODUCTION: We aim to evaluate the mortality benefit from defibrillator therapy in eligible elderly patients. Effective primary prevention of sudden cardiac death with implantable cardioverter defibrillators is well demonstrated in patients with coronary ...
Full textLink to itemCite
Journal ArticleJAMA · July 25, 2007
Featured Publication
CONTEXT: Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely res ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2007
Featured Publication
Long QT syndrome (LQTS) is one of several primary electrical disorders or hereditary arrhythmia syndromes along with the short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. Since its initial recognition in 1957 b ...
Full textLink to itemCite
Journal ArticleCardiol J · 2007
BACKGROUND: Inability to perform defibrillation threshold (DFT) testing during implantable cardioverter defibrillator (ICD) implantation due to co-morbidities may influence long-term survival. METHODS: Retrospective review at The University of Michigan (19 ...
Link to itemCite
Journal ArticleJ Interv Card Electrophysiol · November 2006
BACKGROUND: The number of catheter ablations performed for atrial fibrillation (AF) has increased dramatically over the past several years. Regional variation in left atrial (LA) wall thickness is known to exist but have not been described in detail. AF ab ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · September 2006
INTRODUCTION: Nicotine elevates serum catecholamine concentration and is therefore potentially arrhythmogenic. However, the effect of cigarette smoking on arrhythmic risk in coronary heart disease patients is not well established. METHODS AND RESULTS: The ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2006
BACKGROUND: Atrial fibrillation (AF) contributes to increased risk of morbidity and mortality. Data regarding the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in AF patients are limited. OBJECTIVES: The purpose of this study was to ...
Full textLink to itemCite
Journal ArticleCirculation · February 14, 2006
BACKGROUND: Ventricular tachyarrhythmias long enough to cause implantable cardioverter defibrillator (ICD) shocks are generally thought to progress to cardiac arrest. In previous ICD trials, shocks have been considered an appropriate surrogate for sudden c ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · January 3, 2006
Featured Publication
UNLABELLED: In the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II, implantable cardioverter-defibrillator (ICD)-randomized patients underwent electrophysiologic testing. Both inducible and noninducible patients received an ICD. We correl ...
Full textLink to itemCite
Journal ArticleAm J Geriatr Cardiol · 2006
The incidence of sudden cardiac death increases with age and the proportion of the US population in progressively more advanced age strata is dramatically increasing. While several randomized controlled trials support the use of implantable cardioverter-de ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 20, 2005
OBJECTIVES: The InSync III study evaluated sequential cardiac resynchronization therapy (CRT) in patients with moderate-to-severe heart failure and prolonged QRS. BACKGROUND: Simultaneous CRT improves hemodynamic and clinical performance in patients with m ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 20, 2005
Featured Publication
OBJECTIVES: The purpose of this study was to evaluate the safety of implanting a cardiac resynchronization therapy (CRT) system. BACKGROUND: Clinicians and patients require data on the safety of the CRT implant procedure to estimate procedural risk. METHOD ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · November 1, 2005
Featured Publication
OBJECTIVES: The purpose of this study was to prospectively examine the role of clinical, laboratory, echocardiographic, and electrophysiological variables as predictors of appropriate initial implantable cardioverter-defibrillator (ICD) therapy for ventric ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · October 2005
The planned MADIT-CRT trial is designed to determine if CRT-D will reduce the risk of mortality and HF events by approximately 25% in subjects with ischemic (NYHA class I-II) and non-ischemic (NYHA class II) cardiomyopathy, left ventricular dysfunction (EF ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · October 2005
Featured Publication
BACKGROUND: We conducted a study of chronic therapy with flecainide versus placebo in a small group of LQT-3 patients with the DeltaKPQ deletion to evaluate the safety and efficacy of flecainide in this genetic disorder. In vitro studies have shown that fl ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 1, 2005
This study examined the effects of beta blockers on (1) appropriate implantable cardioverter defibrillator (ICD) therapy for ventricular tachycardia (VT) or ventricular fibrillation (VF), (2) inappropriate ICD therapy for atrial fibrillation or supraventri ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · June 2005
Venous complications of pacemaker/ implantable cardioverter defibrillator (ICD) system implantation rarely cause immediate clinical problems. The challenge starts when patients come for system revision or upgrade. Numerous reports of venous complications s ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · April 2005
Featured Publication
INTRODUCTION: This study was designed to assess whether right ventricular pacing in the implantable cardioverter defibrillator (ICD) arm of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II was associated with an unfavorable outcome. ME ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · January 2005
Featured Publication
We sought to evaluate prospectively the safety and efficacy of cryothermal energy to ablate typical atrial flutter (AFL). Ablation of cardiac tissue using cryothermal energy has recently been developed as an alternative to radiofrequency energy, which may ...
Full textLink to itemCite
Journal ArticleCirculation · December 21, 2004
BACKGROUND: The implanted cardioverter defibrillator (ICD) improves survival in high-risk cardiac patients. This analysis from the MADIT-II trial database examines the long-term clinical course and subsequent mortality risk of patients after termination of ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · September 2004
Many randomized trials of implantable cardioverter defibrillator (ICD) therapy versus medical treatment for the prevention of death in survivors of cardiac arrest or in patients at high risk of sudden cardiac death (SCD) have been reported. ICD therapy has ...
Full textLink to itemCite
Journal ArticleN Engl J Med · May 20, 2004
Featured Publication
BACKGROUND: Patients with nonischemic dilated cardiomyopathy are at substantial risk for sudden death from cardiac causes. However, the value of prophylactic implantation of an implantable cardioverter-defibrillator (ICD) to prevent sudden death in such pa ...
Full textLink to itemCite
Journal ArticleCirculation · April 27, 2004
BACKGROUND: Expectations that reestablishing and maintaining sinus rhythm in patients with atrial fibrillation might improve survival were disproved in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. This report describ ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · October 2003
Increased repolarization variability has been observed in various cardiac conditions. However, data on its relation to heart rate variability and on its value in predicting adverse outcomes in high risk patients are limited. Forty-seven patients with decre ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · April 2003
Featured Publication
INTRODUCTION: Implantable cardioverter defibrillators (ICDs) are increasingly being used in high-risk long QT syndrome (LQTS) patients, but there are limited data regarding clinical experience with this therapeutic modality. The aim of this study is to des ...
Full textLink to itemCite
Journal ArticleCard Electrophysiol Rev · December 2002
Featured Publication
The MADIT-II trial showed that in patients with a prior myocardial infarction and ejection fraction
Full textLink to itemCite
Journal ArticleN Engl J Med · March 21, 2002
Featured Publication
BACKGROUND: Patients with reduced left ventricular function after myocardial infarction are at risk for life-threatening ventricular arrhythmias. This randomized trial was designed to evaluate the effect of an implantable defibrillator on survival in such ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · July 1, 2001
The aim of this study was to determine the prognostic significance of nonlinear and standard heart rate (HR) variability parameters in predicting future adverse events (AEs) in patients with implantable cardioverter-defibrillators. In postinfarction studie ...
Full textLink to itemCite
Journal ArticleJ Card Fail · December 2000
Up to 50% of patients with chronic systolic heart failure have interventricular conduction delays, such as left bundle branch block, that result in abnormal electrical depolarization of the heart. Prolonged QRS duration results in abnormal interventricular ...
Full textLink to itemCite
Journal ArticleN Engl J Med · February 10, 2000
BACKGROUND: Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients. METHODS: We conducted a retrospective multicenter study of the efficacy of implantable cardi ...
Full textLink to itemCite
Journal ArticleComputers in Cardiology · December 1, 1999
Identifying patients at risk for atrial fibrillation (AF) is a major task of noninvasive electrophysiology. In this study, we aimed to evaluate the usefulness of a wavelet transformation method describing spatial dispersion of time-frequency components of ...
Cite
Journal ArticleHeart Lung · 1999
All permanent pacemakers and implantable defibrillators (PPM/ICDs) will continue to function as programmed without regard to the date in the year 2000 (Y2K). All manufacturers contacted reassured us that some of these devices incorporate a day/year clock i ...
Full textLink to itemCite
Journal ArticleJ Med Chem · July 2, 1998
The synthesis and biological activity of a methylamine-bridged enkephalin analogue (MABE) is presented. The key step in the synthesis of the target compound involves the ring opening of Cbz-d-serine beta-lactone with Boc-Phe-NHCH2CH2NHCH3. Further syntheti ...
Full textLink to itemCite
Journal ArticleN Engl J Med · November 27, 1997
BACKGROUND: Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be treated with either an implantable cardioverter-defibrillator or antiarrhythmic drugs, but the relative efficacy of these two treat ...
Full textLink to itemCite
Journal ArticleAnnals of Noninvasive Electrocardiology · April 24, 1997
Nonsustained ventricular tachycardia (VT) has been an intimidating diagnosis for many physicians because its presence, in general, portends an increased risk of sudden death. The management and approach has been quite diverse and inconsistent in part due t ...
Full textCite
Journal ArticleN Engl J Med · December 26, 1996
BACKGROUND: Unsustained ventricular tachycardia in patients with previous myocardial infarction and left ventricular dysfunction is associated with a two-year mortality rate of about 30 percent. We studied whether prophylactic therapy with an implanted car ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · April 1996
Cardiomyopathy and congestive heart failure due to ventricular and supraventricular tachycardia is a well-recognized phenomenon. The mechanism of such cardiomyopathy is not clear. Ablation of the supraventricular tachycardia focus, either surgically or ele ...
Full textLink to itemCite
Journal ArticleDrugs Aging · June 1994
The treatment of ventricular arrhythmias in the elderly population is a challenging problem. Elderly patients are more predisposed to arrhythmias, are less responsive to antiarrhythmic agents and are more susceptible to the adverse effects of antiarrhythmi ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · May 1994
While ventricular electrophysiological properties have been intensively studied at normal heart rates, little is known about these properties at the very short cycle lengths (approximately 100 msec), which are present in ventricular fibrillation. We examin ...
Full textLink to itemCite
Journal ArticleCathet Cardiovasc Diagn · February 1994
Complete heart block (CHB) following retrograde left ventricular catheterization is uncommon. We report a case of transient CHB in a patient with severe aortic stenosis and bifascicular block on the baseline surface electrocardiogram during retrograde left ...
Full textLink to itemCite
Journal ArticleAm J Med · March 1993
Distinguishing constrictive pericarditis from restrictive cardiomyopathy, usually due to amyloidosis, is a relatively frequent and difficult diagnostic problem. This report describes, for the first time, a patient with constrictive pericarditis caused by d ...
Full textLink to itemCite
Journal ArticleCirc Res · January 1993
To study the mechanism of defibrillation and the reason for the increased defibrillation efficacy of biphasic waveforms, the potential gradient in a 32 x 30-mm region of the right ventricle in 15 dogs was progressively lowered in four steps while a strong ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · July 1992
UNLABELLED: Cardioversion shocks given during ventricular tachycardia may cause ventricular fibrillation or acceleration of ventricular tachycardia, or arrest the tachycardia. A recently proposed theory may explain why the former two phenomena may occur. B ...
Full textLink to itemCite
Journal ArticleCirculation · December 1991
Featured Publication
BACKGROUND: Certain biphasic waveforms defibrillate at lower energies than monophasic waveforms, although the mechanism is unknown. METHODS AND RESULTS: The relative ability of monophasic and biphasic shocks to stimulate partially refractory myocardium was ...
Full textLink to itemCite
Journal ArticleCirc Res · May 1990
During internal defibrillation, potential gradients greater than 100 V/cm occur near defibrillation electrodes. Such strong fields may cause deleterious effects, including arrhythmias. This study determined 1) the effects of such strong fields on the propa ...
Full textLink to itemCite
Journal ArticleOphthalmic Plast Reconstr Surg · 1990
Using quantitative lacrimal scintillography, tear flow in the normal state was analyzed in 11 asymptomatic volunteers. The results were compared to states with the superior punctum occluded, and to those with the inferior punctum occluded. No significant d ...
Full textLink to itemCite